Sevrage en ambulatoire d’un traitement par opiacés chez des patients souffrant de douleur chronique [Tapering of opioid-based pain treatment for chronic pain patients in an outpatient setting]
Fiche du document
21 juin 2023
- doi: 10.53738/REVMED.2023.19.832.1224
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.832.1224
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37341314
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_10DDD786A5D99
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-12-21 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Citer ce document
M.D. Gutzmann et al., « Sevrage en ambulatoire d’un traitement par opiacés chez des patients souffrant de douleur chronique [Tapering of opioid-based pain treatment for chronic pain patients in an outpatient setting] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.832.1224
Métriques
Partage / Export
Résumé
Caring for chronic pain patients under opioid therapy is challenging. Opioid treatments above 50 milligrams morphine equivalents (MME) per day are associated with an increased risk of morbidity and mortality. A tapering or a discontinuation should be discussed. Shared decision-making with individualized goals and motivational interviewing principles should be used. Tapering should be slow, with initial rate based on the duration of opioid use and with regular monitoring of patients. Inability to taper may require further reassessment of opioid dependence. Temporary increases in pain may occur at the start of tapering, but pain may improve or remain unchanged upon completion of tapering.